AI’s Impact on Healthcare
AI’s Impact on Healthcare
– This session will examine how artificial intelligence is changing healthcare today and
how it may transform clinical practice, research, operations, medical education, and
therapeutic development in the years ahead.
– The discussion will address AI-enabled diagnosis, clinical decision support, drug
discovery, patient monitoring, documentation, workflow automation, regulatory
oversight, bias, trust, data privacy, and physician accountability.
– Panelists will focus on both the promise and the risks of AI, with particular attention to
how AI can improve outcomes, reduce burden, and expand access while preserving
safety, transparency, and the human dimension of medicine.
PANELISTS:
Shubh Chavda
Director Software Engineering
Shubh Chavda is a senior IT leader with over 20 years of experience driving large-scale distributed systems, AI and cloud architecture across the tech, biotech, and fintech sectors. During engineering leadership roles at Click Therapeutics, Apple, Capital One, and Sabre, Shubh has specialized in scaling high-velocity engineering organizations and integrating modern AI/ML solutions within heavily regulated environments. Read full profile…
Dr. Chung Hyuk Park
Associate Professor, The George Washington University | Socially Assistive Robotics, Human-Robot Interaction
Dr. Chung Hyuk Park is a Professor in the Department of Biomedical Engineering, School of Engineering and Applied Science at the George Washington University. As the director of the Assistive Robotics and Tele-Medicine (ART-Med) Lab, his current research interests are: 1) Multimodal human-robot interaction (HRI) and robotic assistance for individuals with disabilities or special needs, 2) Robotic learning and humanized intelligence, 3) Tele-medical robotic assistance and AI-based reasoning for medical perception and decision-making, 4) Trustworthiness in Embodied AI, and 5) Physical AI and Neuro-Sybolic Learning. Read full profile…
Shashank J. Patel, Ph.D.
Founder & Chief Executive Officer, Monocacy Therapeutics Inc.
Dr. Shashank J. Patel is an immunologist, gene-engineer, and biotech entrepreneur with more
than 15 years of leadership experience spanning academia, government, and global biopharma. He is the Founder and CEO of Monocacy Therapeutics Inc., an AI-native immunotherapy company pioneering first-in-class small molecules and engineered biologics to overcome resistance to immune checkpoint therapy and expand access to transformative cancer treatments. Read full profile…
Vijay Walia, PhD MBA
Sr. Director, Regulatory Affairs at Quest Diagnostics
Dr. Vijay Walia is a Sr. Director, Regulatory Affairs at Quest Diagnostics leading regulatory strategy for oncology and software-based devices. Dr. Walia is an expert in US FDA negotiations, Breakthrough Designations, PMA, DeNovo, 510(k), pre-submissions, Design Controls, AI-based devices, and Software & Cybersecurity for IVDs and Medical Devices. Dr. Walia is an expert in US FDA negotiations, Breakthrough Designations, PMA, DeNovo, 510(k), pre-submissions, Design Controls, AI-based devices, and Software & Cybersecurity for IVDs and Medical Devices. Read full profile…